about
Multimeric structures of HLA-G isoforms function through differential binding to LILRB receptorsThe dual role of HLA-G in cancerRecombinant HLA-G as Tolerogenic Immunomodulant in Experimental Small Bowel TransplantationHLA-G up-regulates ILT2, ILT3, ILT4, and KIR2DL4 in antigen presenting cells, NK cells, and T cellsTolerogenic function of dimeric forms of HLA-G recombinant proteins: a comparative study in vivoSynthetic HLA-G proteins for therapeutic use in transplantation.CD3+CD4low and CD3+CD8low are induced by HLA-G: novel human peripheral blood suppressor T-cell subsets involved in transplant acceptance.Expression of tolerogenic HLA-G molecules in cancer prevents antitumor responses.Different functional outcomes of intercellular membrane transfers to monocytes and T cells.The role of HLA-G in immunity and hematopoiesis.Proper regrafting of Ig-like transcript 2 after trogocytosis allows a functional cell-cell transfer of sensitivity.The tolerogenic interplay(s) among HLA-G, myeloid APCs, and regulatory cells.Intercellular exchanges of membrane patches (trogocytosis) highlight the next level of immune plasticity.Exchanges of membrane patches (trogocytosis) split theoretical and actual functions of immune cells.HLA-G in transplantation: a relevant molecule for inhibition of graft rejection?Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology.Heteroclitic immunization induces tumor immunityFunctions of HLA-G in the immune system.Research on HLA-G: an update.HLA-G-dependent suppressor cells: Diverse by nature, function, and significance.A Systematic Review of Immunotherapy in Urologic Cancer: Evolving Roles for Targeting of CTLA-4, PD-1/PD-L1, and HLA-G.HLA-G: An Immune Checkpoint Molecule.Novel landscape of HLA-G isoforms expressed in clear cell renal cell carcinoma patients.Expression and differential regulation of HLA-G isoforms in the retinal pigment epithelial cell line, ARPE-19.The role of methylation, DNA polymorphisms and microRNAs on HLA-G expression in human embryonic stem cells.Pseudomonas aeruginosa Quorum Sensing Molecule N-(3-Oxododecanoyl)-L-Homoserine-Lactone Induces HLA-G Expression in Human Immune CellsTrogocytic intercellular membrane exchanges among hematological tumors.HLA-G inhibition of NK-cell cytolytic function is uncoupled from tumor cell lipid raft reorganization.Identification of circulating nonclassic human leukocyte antigen G (HLA-G)-like molecules in exudates.Inhibition of human gamma delta [corrected] T-cell antitumoral activity through HLA-G: implications for immunotherapy of cancer.Linking two immuno-suppressive molecules: indoleamine 2,3 dioxygenase can modify HLA-G cell-surface expression.Functional evidence that conserved TCR CDR alpha 3 loop docking governs the cross-recognition of closely related peptide:class I complexes.HLA-G expression levels influence the tolerogenic activity of human DC-10.Effect of age on humoral immunity, selection of the B-cell repertoire and B-cell development.In vivo identification of an HLA-G complex as ubiquitinated protein circulating in exosomes.Report of the Wet Workshop for Quantification of Soluble HLA-G in Essen, 2004.Quantification and identification of soluble HLA-G isoforms.Intratumor heterogeneity of immune checkpoints in primary renal cell cancer: Focus on HLA-G/ILT2/ILT4.The HLA-G Genetic Contribution to Bipolar Disorder: A Trans-Ethnic Replication.Multiplex bead-based immunoassay for the free soluble forms of the HLA-G receptors, ILT2 and ILT4.
P50
Q24293562-A7B43560-2C32-485F-B452-5591E07F423FQ26860886-E0BAA3E9-EB58-4F9D-836D-F44A4852CDACQ27334902-C9113616-68D1-4834-8B2D-2F46C3833750Q28304268-EC6A75D4-2AE4-4764-B980-7C9E16F23704Q28742634-54639023-8F98-43A9-BED7-991CE640D081Q30543621-DCBF460F-45FA-4357-A382-E2539EE8000EQ34006562-1E958BD0-257C-48D3-A20A-0B4118F0B471Q34007049-06A62379-0027-4DC7-BC58-257513DEECA0Q34021678-CB0155B5-0A65-495C-BBC8-F59C3FC322E5Q34024865-9C4AE9EE-A5EE-4C11-B414-AF4818EB3D8FQ34025363-E51677A3-6B9A-48FB-B8D3-CF7B28AC1212Q34028793-5D58A03D-89E0-47E4-B69C-506A60CCC99DQ34573148-2FA6506F-91E5-4193-9BEF-F57891419944Q34578243-FC846213-CC0D-4AEC-89B0-A548EFE6C43DQ35030797-04302C33-F1EF-4411-92CE-81FEB986DACFQ36281215-1B0D28F6-8E2E-4301-B224-A0934CCDBA7EQ36401743-0B989CA8-AE08-4ADF-82A1-AF027B8E9B38Q36795981-2BE42E51-2035-42D9-A495-EFFC2F77924FQ36817290-3E112CBD-84A7-4416-B173-88598E7D9F90Q37279472-BCAE692A-BC0E-49F9-8848-416C26FBCC51Q38396717-12289433-31F0-44E5-9852-A5F0CC41CC40Q38527620-979793A1-D2C6-42F1-B3D1-F11BE6A0B558Q38620814-113648DF-1B92-4A25-A6A6-AAB044C11512Q38706111-4F1ABA5F-1DC3-4E69-939D-DD180475613CQ38764724-BC459AAC-BF87-4095-A681-3DB05B85BC72Q38850936-82A91FAE-98C2-4837-95F0-9DC82A34F249Q38885565-FBBB5824-B837-4392-91D8-06B4D41BBE21Q39432611-8DEE84D6-BC28-466A-9E89-C393A879D0F3Q39551417-FF115698-F8C1-4EE9-9504-49C00B5BC6C8Q39588867-2A4CC67E-24E8-4CF4-8C0A-70C96B77C4FFQ40425713-38E0CB69-E0FF-40B1-81EF-685AB6E484B7Q40794225-103DB085-4BC7-474D-B326-810CE879420FQ41465101-76E572EA-E66C-42FC-8695-2F6B7002E008Q41708786-1F533EBE-7BB5-4697-8486-14D2C0EE1111Q51066607-7986494F-88CD-4493-8A31-769A240975B0Q52661569-AE7AB78E-1B71-46BE-8B6F-CEBF900D3BBAQ52679127-D7202885-81C4-4F76-AD05-78085AABB895Q53064214-11941E8B-D431-41DA-8396-9B8B7989A991Q54218311-C85E90BE-48BA-43D9-8F6B-C6070B8FBA21Q55059584-BA3EDB22-9C4F-4B1C-9612-3BE2BBA5DA5A
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Joel LeMaoult
@ast
Joel LeMaoult
@en
Joel LeMaoult
@es
Joel LeMaoult
@nl
Joel LeMaoult
@sl
type
label
Joel LeMaoult
@ast
Joel LeMaoult
@en
Joel LeMaoult
@es
Joel LeMaoult
@nl
Joel LeMaoult
@sl
prefLabel
Joel LeMaoult
@ast
Joel LeMaoult
@en
Joel LeMaoult
@es
Joel LeMaoult
@nl
Joel LeMaoult
@sl
P106
P21
P31
P3762
P496
0000-0002-4513-9482